DOI:

How to become an Andreas Grüntzig in the 21st century

How to become an Andreas Grüntzig in the 21 century

Bernhard Meier

The contributions of Andreas Grüntzig to modern medicine are huge, though it may be argued that serendipity accounted for a significant part of his success. He came to Zürich to be a disciple of Robert Hegglin, an internist. Hegglin died shortly after Grüntzig’s arrival, obliging him to find a substitute tutor in the person of Alfred Bollinger, an angiologist, whose diagnostic skills he quickly acquired.

As a step still further, Grüntzig then became intrigued by the fact that unblocking arteries appeared to be conceptually simple. Charles Dotter had already shown how to dilate peripheral arteries with incremental catheters and Dotter must have given balloons a thought. However, it was Grüntzig who happened to run into a plastics expert who knew how to make a functioning dilatation balloon. Grüntzig appeared to be in danger of jeopardising the sovereignty of cardiac surgery and yet it just so happened that Åke Senning was the local chief surgeon. Senning already enjoyed considerable personal fame and was happy to share the limelight with this young cardiologist in the ascendant who was threatening to eclipse him. Lastly, Grüntzig’s first case just happened to be as good as they come – almost forty years on, his first patient has never needed bypass surgery!

While such a constellation was unlikely at the time, it would be unthinkable today. Critics would stop a Grüntzig of our times, raising ethical and regulatory red flags. His story could not be reconciled with today’s evidence-based medicine and research rigour. Yet, creative minds continue to exist and, to help them make their dreams come true, specialists have emerged alongside ever more restrictive regulations. Medical breakthroughs are still possible and young physicians must continue to strive for them. They can no longer be accomplished by a single person but the required algorithms and the money still exist. The secret is to think out of the box but not act out of the box. Casey Kasem knew it all along when he proclaimed, “Keep reaching for the stars but keep your feet on the ground”.

Bernhard Meier, MD

Professor of Cardiology, University Hospital of Bern, Bern, Switzerland

[email protected]

NEWS

EAPCI General Assembly Thursday 18 May, 10:30-12:00, Room 343! Join us and and learn about the latest developments of our Association. EAPCI Voting members will be invited to vote on a proposal for a new mission for the Association. Be there! We look forward to seeing you...

Don’t miss the free EAPCI webinar on 23 June, from 18:00 to 19:00 CET.

Join Dr R. Byrne, Professors M. Roffi and A. Baumbach for a “Focus on bleeding management strategy in patients under oral anticoagulation after PCI – from randomized clinical trials to the individual patient”.

Register online: www.escardio.org/EAPCI - Education section

Keep up to date about all the exciting upcoming European Society of Cardiology (ESC) webinars at www.escardio.org - Education section

Volume 13 Number 1
May 15, 2017
Volume 13 Number 1
View full issue

Suggested by Cory

Editorial

10.4244/EIJ-D-26-00453 Jul 6, 2026
AnchorMan versus Watchman 2.5: a randomised comparison in left atrial appendage closure
Garot P and Nielsen-Kudsk J
free

Editorial

10.4244/EIJ-E-26-00011 Jul 6, 2026
Comparing transcatheter aortic valves: time to look beyond simplistic categorisations
Blackman D and Maznyczka A
free

Original Research

10.4244/EIJ-D-26-00158 Jul 6, 2026
Prosthesis-patient mismatch with intra-annular self-expanding valves: an analysis of the PORTICO IDE trial
Fontana G et al

Research Correspondence

10.4244/EIJ-D-26-00315 Jul 6, 2026
Validation of the VARC-HBR consensus for defining high bleeding risk in TAVI
Singh M et al

Research Correspondence

10.4244/EIJ-D-26-00271 Jul 6, 2026
Outcomes of percutaneous mechanical aspiration in left-sided infective endocarditis
Lugo-Fagundo NS et al

Flashlight

10.4244/EIJ-D-26-00128 Jul 6, 2026
Concomitant transfemoral aortic and mitral valve replacement
Lianos I et al
Trending articles
334.7

State-of-the-Art Review

10.4244/EIJ-D-21-00904 Apr 1, 2022
Antiplatelet therapy after percutaneous coronary intervention
Angiolillo D et al
free
84.05

State-of-the-Art

10.4244/EIJ-D-23-00840 Sep 2, 2024
Aortic regurgitation: from mechanisms to management
Baumbach A et al
free
45.75

State-of-the-Art

10.4244/EIJ-D-25-01346 May 4, 2026
Slow flow and no reflow after percutaneous coronary intervention
Brugaletta S et al
free
42.15

State-of-the-Art

10.4244/EIJ-D-25-00896 Apr 6, 2026
Pretreatment with antiplatelet agents in patients undergoing coronary revascularisation
Kaur G et al
free
38.2

State-of-the-Art

10.4244/EIJ-D-24-00195 Apr 7, 2025
Percutaneous coronary intervention for calcified and resistant lesions
Pesarini G et al
free
33.5

Original Research

10.4244/EIJ-D-26-00032 May 15, 2026
Glucocorticoids to reduce permanent pacemaker implantation after TAVI: the GLUCO-TAVI randomised trial
Fuertes-Kenneally L et al
32.2

State-of-the-Art

10.4244/EIJ-D-25-00874 Jun 1, 2026
TAVI and coronary interventions: indications, technical considerations, and clinical scenarios
Aquino Bruno H et al
free
29.2

Original Research

10.4244/EIJ-D-25-01370 May 21, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
29.2

Original Research

10.4244/EIJ-D-25-01370 Jun 1, 2026
Prognostic value of early haemodynamic valve deterioration after TAVI
Trimaille A et al
X

PCR
Impact factor: 9.2
2025 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2026)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2026 Europa Group - All rights reserved